Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 May 18;14(5):513.
doi: 10.3390/brainsci14050513.

mTBI Biological Biomarkers as Predictors of Postconcussion Syndrome-Review

Affiliations
Review

mTBI Biological Biomarkers as Predictors of Postconcussion Syndrome-Review

Ewelina Stępniewska et al. Brain Sci. .

Abstract

Postconcussion syndrome (PCS) is one of the leading complications that may appear in patients after mild head trauma. Every day, thousands of people, regardless of age, gender, and race, are diagnosed in emergency departments due to head injuries. Traumatic Brain Injury (TBI) is a significant public health problem, impacting an estimated 1.5 million people in the United States and up to 69 million people worldwide each year, with 80% of these cases being mild. An analysis of the available research and a systematic review were conducted to search for a solution to predicting the occurrence of postconcussion syndrome. Particular biomarkers that can be examined upon admission to the emergency department after head injury were found as possible predictive factors of PCS development. Setting one unequivocal definition of PCS is still a challenge that causes inconsistent results. Neuron Specific Enolase (NSE), Glial Fibrillary Acidic Protein (GFAP), Ubiquitin C-terminal Hydrolase-L1 (UCH-L1), Serum Protein 100 B (s100B), and tau protein are found to be the best predictors of PCS development. The presence of all mentioned biomarkers is confirmed in severe TBI. All mentioned biomarkers are used as predictors of PCS. A combined examination of NSE, GFAP, UCH-1, S100B, and tau protein should be performed to detect mTBI and predict the development of PCS.

Keywords: biomarker; mild traumatic brain injury; postconcussion syndrome.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

References

    1. Begaz T., Kyriacou D.N., Segal J., Bazarian J.J. Serum Biochemical Markers for Post-Concussion Syndrome in Patients with Mild Traumatic Brain Injury. J. Neurotrauma. 2006;23:1201–1210. doi: 10.1089/neu.2006.23.1201. - DOI - PubMed
    1. Dewan M.C., Rattani A., Gupta S., Baticulon R.E., Hung Y.-C., Punchak M., Agrawal A., Adeleye A.O., Shrime M.G., Rubiano A.M., et al. Estimating the Global Incidence of Traumatic Brain Injury. J. Neurosurg. 2018;130:1080–1097. doi: 10.3171/2017.10.JNS17352. - DOI - PubMed
    1. Mavroudis I., Kazis D., Chowdhury R., Petridis F., Costa V., Balmus I.-M., Ciobica A., Luca A.-C., Radu I., Dobrin R.P., et al. Post-Concussion Syndrome and Chronic Traumatic Encephalopathy: Narrative Review on the Neuropathology, Neuroimaging and Fluid Biomarkers. Diagnostics. 2022;12:740. doi: 10.3390/diagnostics12030740. - DOI - PMC - PubMed
    1. Diagnostic Criteria for Postconcussional Syndrome After Mild to Moder. [(accessed on 24 March 2024)]. Available online: https://archive.ph/qUuDK.
    1. Varriano B., Tomlinson G., Tarazi A., Wennberg R., Tator C., Tartaglia M.C. Age, Gender and Mechanism of Injury Interactions in Post-Concussion Syndrome. Can. J. Neurol. Sci. 2018;45:636–642. doi: 10.1017/cjn.2018.322. - DOI - PubMed

LinkOut - more resources